Please try another search
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia; NEX-20 for the treatment of multiple myeloma; and NEX-22 for the treatment of type 2 diabetes. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Jose Miguel Torregrosa Diaz | - | - | Member of Advisory Board - NEX-18 |
Richard Davis | 51 | 2022 | Independent Director |
Robert Peter Gale | - | - | Member of Advisory Board - NEX-18 |
Christopher Maisel | - | - | Member of Advisory Board - NEX-20 |
Jakob Dynnes Hansen | 69 | 2023 | Independent Director |
Magnus Westgren | 74 | 2015 | Independent Director |
Birgit Stattin Norinder | 76 | 2021 | Independent Director |
Eva Nilsagard | 60 | 2021 | Independent Director |
Goran A. Ando | 75 | 2020 | Independent Chairman of the Board |
Marie von Lilienfeld-Toa | - | - | Member of Advisory Board - NEX-20 |
Magnus Tobiasson | - | - | Member of Advisory Board - NEX-18 |
Karthik Ramasamy | - | - | Member of Advisory Board - NEX-20 |
Kirsten Gronbaek | - | - | Member of Advisory Board - NEX-18 |
Xavier Leleu | - | - | Member of Advisory Board - NEX-20 |
Uwe Platzbecker | - | - | Member of Advisory Board - NEX-18 |
Axel Gaston Glasmacher | 64 | - | Member of Advisory Board - NEX-18 & NEX-20 |
Hanna Tilus | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review